{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:38:50Z","timestamp":1772249930400,"version":"3.50.1"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI001275 AI001195"],"award-info":[{"award-number":["AI001275 AI001195"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    Angiotensin-converting enzyme 2 (ACE2) is the established cellular receptor for SARS-CoV-2. However, it is unclear whether ACE1 inhibitors (e.g., lisinopril) or angiotensin receptor blockers (e.g., losartan) alter tissue ACE2 expression. This study sought to determine whether lisinopril or losartan, as monotherapies or in combination, changes tissue levels of ACE2 in healthy male and female mice. Mice received lisinopril (10\u00a0mg\/kg\/day), losartan (10\u00a0mg\/kg\/day), or both for 21\u00a0days via drinking water. A control group received water without drug. The ACE2 protein index (ACE2 protein\/total protein) was determined on the small intestine, lung, kidney, and brain. Oral lisinopril increased the ACE2 protein index across all tissues (\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.0001 vs. control). In contrast, the combination of lisinopril plus losartan did not increase ACE2 levels in any tissue (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.89 vs. control) and even decreased tissue expression of the\n                    <jats:italic>Ace2<\/jats:italic>\n                    gene (\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.001 vs. control). Tissue ACE2 remained elevated in the mice 21\u00a0days after cessation of lisinopril (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.02). Plasma ACE2 did not correlate with the ACE2 protein index in any tissue. A sex difference was observed: kidney ACE2 levels were higher in male than in female mice (\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.0001). Oral lisinopril increases ACE2, the cellular receptor for SARS-CoV-2, in tissues that are relevant to the transmission and pathogenesis of COVID-19. Remarkably, the addition of losartan prevented lisinopril-induced increases in ACE2 across tissues. These results suggest that ACE inhibitors and angiotensin receptor blockers interact to determine tissue levels of ACE2.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2022.798349","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T10:11:27Z","timestamp":1646907087000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Oral Lisinopril Raises Tissue Levels of ACE2, the SARS-CoV-2 Receptor, in Healthy Male and Female Mice"],"prefix":"10.3389","volume":"13","author":[{"given":"Steven D.","family":"Brooks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline S.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans C.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ijid.2020.04.057","article-title":"Potential Fecal Transmission of SARS-CoV-2: Current Evidence and Implications for Public Health","volume":"95","author":"Amirian","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m1313","article-title":"Drugs and the renin-angiotensin system in covid-19","volume-title":"BMJ","author":"Aronson","year":"2020"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e213594","DOI":"10.1001\/jamanetworkopen.2021.3594","article-title":"Association between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-Analysis","volume":"4","author":"Baral","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"B3","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1097\/HJH.0000000000002784","article-title":"Renin-angiotensin-system Inhibitors and All-Cause Mortality in Patients with COVID-19: a Systematic Review and Meta-Analysis of Observational Studies","volume":"39","author":"Bavishi","year":"2021","journal-title":"J. Hypertens."},{"key":"B4","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1001\/jamapsychiatry.2021.0500","article-title":"How COVID-19 Affects the Brain","volume":"78","author":"Boldrini","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41422-020-0327-4","article-title":"COVID-19: towards Understanding of Pathogenesis","volume":"30","author":"Cao","year":"2020","journal-title":"Cell Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fped.2020.00206","article-title":"COVID-19 Infection and Circulating ACE2 Levels: Protective Role in Women and Children","volume":"8","author":"Ciaglia","year":"2020","journal-title":"Front. Pediatr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S2213-2600(20)30558-0","article-title":"Continuation versus Discontinuation of Renin-Angiotensin System Inhibitors in Patients Admitted to Hospital with COVID-19: a Prospective, Randomised, Open-Label Trial","volume":"9","author":"Cohen","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"taaa041","DOI":"10.1093\/jtm\/taaa041","article-title":"Hypothesis: Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers May Increase the Risk of Severe COVID-19","volume":"27","author":"Diaz","year":"2020","journal-title":"J. Trav. Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1016\/S2213-2600(20)30159-4","article-title":"Antihypertensive Drugs and Risk of COVID-19? - Authors' Reply","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"B12","first-page":"197","article-title":"Angiotensin II-Inhibiting Drugs Have No Effect on Intraneuronal A\u03b2 or Oligomeric A\u03b2 Levels in a Triple Transgenic Mouse Model of Alzheimer's Disease","volume":"3","author":"Ferrington","year":"2011","journal-title":"Am. J. Transl. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41575-021-00416-6","article-title":"Potential Intestinal Infection and Faecal-Oral Transmission of SARS-CoV-2","volume":"18","author":"Guo","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue Distribution of ACE2 Protein, the Functional Receptor for SARS Coronavirus. A First Step in Understanding SARS Pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12933-021-01275-w","article-title":"Expression of the SARS-CoV-2 receptorACE2 in Human Heart Is Associated with Uncontrolled Diabetes, Obesity, and Activation of the Renin Angiotensin System","volume":"20","author":"Herman-Edelstein","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3389\/fphys.2019.01311","article-title":"Mechanisms Responsible for Genetic Hypertension in Schlager BPH\/2 Mice","volume":"10","author":"Jackson","year":"2019","journal-title":"Front. Physiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/gerona\/gly219","article-title":"Chronic Treatment with the ACE Inhibitor Enalapril Attenuates the Development of Frailty and Differentially Modifies Pro- and Anti-inflammatory Cytokines in Aging Male and Female C57BL\/6 Mice","volume":"74","author":"Keller","year":"2019","journal-title":"J. Gerontol. A. Biol. Sci. Med. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.1111\/jcmm.16310","article-title":"Pulmonary, Cardiac and Renal Distribution of ACE2, Furin, TMPRSS2 and ADAM17 in Rats with Heart Failure: Potential Implication for COVID-19 Disease","volume":"25","author":"Khoury","year":"2021","journal-title":"J. Cel. Mol. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0252799","DOI":"10.1371\/journal.pone.0252799","article-title":"Plasma ACE2 Predicts Outcome of COVID-19 in Hospitalized Patients","volume":"16","author":"Kragstrup","year":"2021","journal-title":"PLOS ONE"},{"key":"B21","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A Crucial Role of Angiotensin Converting Enzyme 2 (ACE2) in SARS Coronavirus-Induced Lung Injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e9946","DOI":"10.1371\/journal.pone.0009946","article-title":"Meta-Analysis of Combined Therapy with Angiotensin Receptor Antagonists versus ACE Inhibitors Alone in Patients with Heart Failure","volume":"5","author":"Kuenzli","year":"2010","journal-title":"PLOS ONE"},{"key":"B23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.7326\/0003-4819-148-1-200801010-00190","article-title":"Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin Angiotensin System on Proteinuria in Renal Disease","volume":"148","author":"Kunz","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41581-021-00452-0","article-title":"Pathophysiology of COVID-19-Associated Acute Kidney Injury","volume":"17","author":"Legrand","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41385-021-00437-z","article-title":"Human Small Intestinal Infection by SARS-CoV-2 Is Characterized by a Mucosal Infiltration with Activated CD8+ T Cells","volume":"14","author":"Lehmann","year":"2021","journal-title":"Mucosal Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting Enzyme 2 Is a Functional Receptor for the SARS Coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12967-019-2021-1","article-title":"Administration of Losartan Preserves Cardiomyocyte Size and Prevents Myocardial Dysfunction in Tail-Suspended Mice by Inhibiting P47phox Phosphorylation, NADPH Oxidase Activation and MuRF1 Expression","volume":"17","author":"Liang","year":"2019","journal-title":"J. Transl. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/2042-6410-1-6","article-title":"Sex Differences in Renal Angiotensin Converting Enzyme 2 (ACE2) Activity Are 17\u03b2-oestradiol-dependent and Sex Chromosome-independent","volume":"1","author":"Liu","year":"2010","journal-title":"Biol. Sex. Differ."},{"key":"B29","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1001\/jama.2020.25864","article-title":"Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted with COVID-19: A Randomized Clinical Trial","volume":"325","author":"Lopes","year":"2021","journal-title":"JAMA"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1042\/CS20200484","article-title":"ACE2, the Kidney and the Emergence of COVID-19 Two Decades after ACE2 Discovery","volume":"134","author":"Lores","year":"2020","journal-title":"Clin. Sci. (Lond)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.14309\/ajg.0000000000000691","article-title":"COVID-19 and the Digestive System","volume":"115","author":"Ma","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1503\/cmaj.101333","article-title":"The Safety of Combining Angiotensin-Converting-Enzyme Inhibitors with Angiotensin-Receptor Blockers in Elderly Patients: a Population-Based Longitudinal Analysis","volume":"183","author":"McAlister","year":"2011","journal-title":"CMAJ"},{"key":"B33","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/S2589-7500(20)30289-2","article-title":"Renin-angiotensin System Blockers and Susceptibility to COVID-19: an International, Open Science, Cohort Analysis","volume":"3","author":"Morales","year":"2021","journal-title":"Lancet Digit. Health"},{"key":"B35","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s13054-020-03120-0","article-title":"Role of Angiotensin-Converting Enzyme 2 (ACE2) in COVID-19","volume":"24","author":"Ni","year":"2020","journal-title":"Crit. Care"},{"key":"B36","doi-asserted-by":"publisher","first-page":"E216","DOI":"10.1148\/radiol.2020201629","article-title":"Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands","volume":"297","author":"Oudkerk","year":"2020","journal-title":"Radiology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1001\/jama.2020.4812","article-title":"COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers","volume":"323","author":"Patel","year":"2020","journal-title":"JAMA"},{"key":"B38","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1042\/cs20201511","article-title":"Experimental Data Using Candesartan and Captopril Indicate No Double-Edged Sword Effect in COVID-19","volume":"135","author":"Pedrosa","year":"2021","journal-title":"Clin. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/infdis\/jiaa332","article-title":"ACE2 Expression Is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19","volume":"222","author":"Pinto","year":"2020","journal-title":"J. Infect. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/ajh\/hpaa169","article-title":"Serum ACE2, Angiotensin II, and Aldosterone Levels Are Unchanged in Patients with COVID-19","volume":"34","author":"Rieder","year":"2021","journal-title":"Am. J. Hypertens."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e016509","DOI":"10.1161\/JAHA.120.016509","article-title":"Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors\/Angiotensin Receptor Blockers Have a Biphasic Effect?","volume":"9","author":"Sommerstein","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"B42","volume-title":"Rapid Reponse Re: Preventing a Covid-19 Pandemic: ACE Inhibitors as a Potential Risk Factor for Fatal Covid-19. 368:m810","author":"Sommerstein","year":"2020"},{"key":"B43","first-page":"167098","volume-title":"RAAS Blockade, Kidney Disease, and Expression of ACE2, the Entry Receptor for SARS-CoV-2, in Kidney Epithelial and Endothelial Cells","author":"Subramanian","year":"2020"},{"key":"B44","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal Coagulation Parameters Are Associated with Poor Prognosis in Patients with Novel Coronavirus Pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/s0140-6736(20)30937-5","article-title":"Endothelial Cell Infection and Endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"The Lancet"},{"key":"B47","doi-asserted-by":"publisher","first-page":"111263","DOI":"10.1016\/j.mce.2021.111263","article-title":"Effect of Ramipril on Kidney, Lung and Heart ACE2 in a Diabetic Mice Model","volume":"529","author":"Vergara","year":"2021","journal-title":"Mol. Cel. Endocrinol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1161\/HYPERTENSIONAHA.120.15782","article-title":"Effects of Renin-Angiotensin Inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Protease Serine 2) Expression: Insights into COVID-19","volume":"76","author":"Wu","year":"2020","journal-title":"Hypertension"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1681\/ASN.2020050667","article-title":"Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19","volume":"31","author":"Wysocki","year":"2020","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.798349\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T10:11:35Z","timestamp":1646907095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.798349\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":49,"alternative-id":["10.3389\/fphar.2022.798349"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.798349","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.10.19.465025","asserted-by":"object"}]},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]},"article-number":"798349"}}